Organisation
Hematology
Current researchers
11 - 17 of 17 results
- Rik (Member)
- Naomi Thielemans (Member)
- Fabienne Trullemans (Member)
- Leen Van Laethem (Member)
- Ivan Van Riet (Member)
- Jana Vanden Broeck (Member)
- Vanessa Vercauteren (Member)
Publications
1 - 10 of 78
- Absence of BCL-2 Expression Identifies a Subgroup of AML with Distinct Phenotypic, Molecular, and Clinical Characteristics(2020)
Authors: Inke De Haes, Amélie Dendooven, Marie Le Mercier, Pauline Puylaert, Katrien Vermeulen, Mark Kockx, Kathleen Deiteren, Marie Maes, Zwi Berneman, Sébastien Anguille
Pages: 1-12 - Assessing the performance of maternity care in Europe(2015)
Authors: Ramón Escuriet, Joanna White, Katrien Beeckman, Lucy Frith, Fatima Leon-Larios, Christine Loytved, Ans Luyben, Marlene Sinclair, Edwin van Teijlingen
- Switching to daratumumab SC from IV is safe and preferred by patients with multiple myeloma(2023)
Authors: Maria-Victoria Mateos, Sophie Rigaudeau, Supratik Basu, Ivan Spicka, Rik Schots, Tomasz Wrobel, Gordon Cook, Meral Beksac, Katharine S Gries, Anupa Kudva, et al.
Pages: 1172-1177 - Heterozygosity for bisphosphoglycerate mutase deficiency expressing clinically as congenital erythrocytosis(2023)
Authors: Myrthe J van Dijk, Brigitte A van Oirschot, Manon C Stam-Slob, Esmé Waanders, Bert van der Zwaag, Eduard J van Beers, Judith J M Jans, Peter Willem van der Linden, Jose M Torregrosa Diaz, Betty Gardie, et al.
Pages: 249-255 - Allogeneic hematopoietic cell transplantation in patients with chronic phase chronic myeloid leukemia in the era of third generation tyrosine kinase inhibitors(2023)
Authors: Yves Chalandon, Giulia Sbianchi, Luuk Gras, Linda Koster, Jane F. Apperley, Jenny L. Byrne, Urpu Salmenniemi, Henrik Sengeloev, Mahmoud Aljurf, Grzegorz Helbig, et al.
Pages: 112-121 - Metformin confers sensitisation to syrosingopine in multiple myeloma cells by metabolic blockage and inhibition of protein synthesis(2023)
Authors: Arne Van der Vreken, Inge Oudaert, Gamze Ates, Sylvia Faict, Philip Vlummens, Hatice Satilmis, Rong Fan, Anke Maes, Ann Massie, Kim De Veirman, et al.
Pages: 112-123 - Intratumoral administration of CD1c (BDCA-1)+ and CD141 (BDCA-3)+ myeloid dendritic cells in combination with talimogene laherparepvec in immune checkpoint blockade refractory advanced melanoma patients(2022)
Authors: Julia Katharina Schwarze, Jens Tijtgat, G Awada, Louise Cras, Angela Vasaturo, Christopher Bagnall, Ramses G Forsyth, Inès Dufait, Sandra Tuyaerts, Ivan Van Riet, et al.
Pages: 1-13 - Dendritic Cells: The Tools for Cancer Treatment(2018)
Authors: Hanne Locy, Sarah Melhaoui, Sarah Maenhout, Kris Thielemans
Pages: 101-128 - Impact of lenalidomide maintenance on the immune environment of multiple myeloma patients with low tumor burden after autologous stem cell transplantation(2018)
Authors: Karel Fostier, Jo Caers, Nathalie Meuleman, Jurgen Corthals, Brenda De Keersmaecker
Pages: 20476-20489 - Predictors of late initiation for prenatal care in a metropolitan region in Belgium. A cohort study(2015)
Authors: Maaike Fobelets, Katrien Beeckman, Annemarie Hoogewys, Mieke Embo, Ronald Buyl, Koen Putman
Pages: 648-654